Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/11683
Title: Labeled rhenium complexes: radiofluorination, α-MSH cyclization, and deuterium substitutions
Authors: Klenner, MA
Darwish, TA
Fraser, BH
Massi, M
Pascali, G
Keywords: Neoplasms
Rhenium
Peptides
Proteins
Rodents
Deuterium
Issue Date: 19-Jun-2020
Publisher: American Chemical Society
Citation: Klenner, M. A., Darwish, T., Fraser, B. H., Massi, M., & Pascali, G. (2020). Labeled rhenium complexes: radiofluorination, α-MSH cyclization, and deuterium substitutions. Organometallics, 39(13), 2334-2351. doi:10.1021/acs.organomet.0c00267
Abstract: While radiopharmaceuticals incorporating rhenium-188 or rhenium-186 radioisotopes have been well documented in the literature, the labeling of rhenium complexes with alternative isotopes has received comparatively less attention. Such rhenium complexes have demonstrated significant utility in imaging melanoma tumors via complexation with α-melanocyte-stimulating hormone (α-MSH) analogues conjugated with radiometals and radiohalogens, improving fluorine-18 incorporation into ligands which were otherwise unable to be synthesized and elucidating improved understandings of rhenium mechanisms and coordination sites through deuterium incorporation. This review highlights each of these rhenium-labeling cases and discusses the benefits derived therein, thus providing a useful resource for researchers intending to label unique rhenium complexes. © 2020 American Chemical Society
URI: https://doi.org/10.1021/acs.organomet.0c00267
https://apo.ansto.gov.au/dspace/handle/10238/11683
ISSN: 1520-6041
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.